A Study to Evaluate ICP-022 in Patients With R/R Mantle Cell Lymphoma (MCL)
Clinical trial NCT03494179 · COMPLETED
Trial details
- NCT number
- NCT03494179
- Sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-02
- Primary completion
- 2020-04-10
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.